| Income Statement |
| Total Revenue | 292.00K |
|
| Revenues (USD) | 292.00K |
| Cost of Revenue | 857.00K |
| Gross Profit | -565.00K |
| Operating Expenses | 1.70M |
| Research and Development Expense | 324.00K |
| Selling, General and Administrative Expense | 1.37M |
| Operating Income | -2.26M |
| Interest Expense | 9.00K |
| Net Income | -2.17M |
| Net Income Common Stock | -2.17M |
| Net Income Common Stock (USD) | -2.17M |
| Consolidated Income | -2.17M |
| Earnings per Basic Share | -0.04 |
| Earnings per Basic Share (USD) | -0.04 |
| Earnings per Diluted Share | -0.04 |
| Earning Before Interest & Taxes (EBIT) | -2.16M |
| Earning Before Interest & Taxes (USD) | -2.16M |
| Weighted Average Shares | 58.02M |
| Weighted Average Shares Diluted | 58.02M |
| Balance Sheet |
| Cash and Equivalents | 358.00K |
| Cash and Equivalents (USD) | 358.00K |
| Trade and Non-Trade Receivables | 664.00K |
| Current Assets | 1.31M |
| Property, Plant & Equipment Net | 51.00K |
| Total Assets | 1.36M |
| Debt Current | 569.00K |
| Total Debt | 701.00K |
| Current Liabilities | 4.73M |
| Debt Non-Current | 132.00K |
| Total Liabilities | 4.88M |
| Accumulated Retained Earnings (Deficit) | -108.99M |
| Shareholders Equity | -3.52M |
| Shareholders Equity (USD) | -3.52M |
| Assets Non-Current | 51.00K |
| Total Debt (USD) | 701.00K |
| Deferred Revenue | 683.00K |
| Liabilities Non-Current | 156.00K |
| Trade and Non-Trade Payables | 3.47M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 5.00K |
| Net Cash Flow from Financing | 1.94M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 125.00K |
| Capital Expenditure | -9.00K |
| Issuance (Purchase) of Equity Shares | 1.12M |
| Issuance (Repayment) of Debt Securities | -136.00K |
| Net Cash Flow from Investing | 56.00K |
| Net Cash Flow - Investment Acquisitions and Disposals | 65.00K |
| Net Cash Flow from Operations | -1.87M |
| Share Based Compensation | 463.00K |